Clinical trials
Phase 2/3 Lung Neoplasms trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
21 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 2 |
| 2005 | 2 |
| 2006 | 1 |
| 2007 | 1 |
| 2011 | 4 |
| 2018 | 1 |
| 2020 | 1 |
| 2022 | 2 |
| 2023 | 1 |
| 2025 | 3 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 6 |
| Active, not recruiting | 5 |
| Completed | 5 |
| Recruiting | 4 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| M.D. Anderson Cancer Center | 3 |
| Bristol-Myers Squibb | 2 |
| SWOG Cancer Research Network | 2 |
| BioNTech SE | 1 |
| Canadian Cancer Trials Group | 1 |
| Genta Incorporated | 1 |
| Memorial Sloan Kettering Cancer Center | 1 |
| NCIC Clinical Trials Group | 1 |
| National Cancer Institute (NCI) | 1 |
| Pierian Biosciences | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lung Neoplasms | 21 |
| Carcinoma, Non-Small-Cell Lung | 11 |
| Breast Neoplasms | 3 |
| Colorectal Neoplasms | 2 |
| Esophageal Neoplasms | 2 |
| Prostatic Neoplasms | 2 |
| Sarcoma | 2 |
| Adenocarcinoma of Lung | 1 |
| Adenoma, Islet Cell | 1 |
| Anorexia | 1 |
Trials
Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.